Toward the Future: The New Challenges of the Cell Therapy and Potential of Regenerative Medicine


by

Nicola Daniele

DOI: 10.2174/97816810843741170101
eISBN: 978-1-68108-437-4, 2017
ISBN: 978-1-68108-438-1



Indexed in: EBSCO.

Cells are the building blocks of life and some cells (stem cells) have the ability to produce other cells through the processes of cel...[view complete introduction]

Exploiting the Role of Hematopoietic Stem Cell Transplantation as a Cure of Hematological and Non Hematological Diseases

- Pp. 56-104 (49)



Abstract

This chapter describes hematopoietic stem cells and their therapeutic uses to cure otherwise lethal, malignant and non-malignant diseases. Here we analyze the biological characteristics of different hematopoietic stem cell sources and how they are mobilized, collected, selected from the patient himself for autologous transplantation, or from matched or mismatched, related or unrelated donors for allogeneic transplantation [1 - 3]. Hematopoietic stem cell transplantation has been implemented for decades and has undergone many improvements over the years [3]. Today it is a safe, feasible option for selected patients and it still remains the only cure for a wide range of malignancies or non-malignant diseases despite advances in understanding disease genetics and biology. Moreover, with improvements in conditioning regimens and graft manipulation [2, 4], cells can be transplanted to enhance immune reconstitution and reduce relapse, which are the most common cause of transplant failure [2, 4]. Given the immunological modulation and anti-leukemic effect of these cells, conditioning regimen can be reduced and transplantation is now extended to elderly patients who are more susceptible to drug toxicity.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science